Suppr超能文献

新型冠状病毒肺炎(COVID-19)概述。

A Review of Coronavirus Disease-2019 (COVID-19).

机构信息

Department of Pediatrics and Infectious Disease, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, India.

出版信息

Indian J Pediatr. 2020 Apr;87(4):281-286. doi: 10.1007/s12098-020-03263-6. Epub 2020 Mar 13.

Abstract

There is a new public health crises threatening the world with the emergence and spread of 2019 novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus originated in bats and was transmitted to humans through yet unknown intermediary animals in Wuhan, Hubei province, China in December 2019. There have been around 96,000 reported cases of coronavirus disease 2019 (COVID-2019) and 3300 reported deaths to date (05/03/2020). The disease is transmitted by inhalation or contact with infected droplets and the incubation period ranges from 2 to 14 d. The symptoms are usually fever, cough, sore throat, breathlessness, fatigue, malaise among others. The disease is mild in most people; in some (usually the elderly and those with comorbidities), it may progress to pneumonia, acute respiratory distress syndrome (ARDS) and multi organ dysfunction. Many people are asymptomatic. The case fatality rate is estimated to range from 2 to 3%. Diagnosis is by demonstration of the virus in respiratory secretions by special molecular tests. Common laboratory findings include normal/ low white cell counts with elevated C-reactive protein (CRP). The computerized tomographic chest scan is usually abnormal even in those with no symptoms or mild disease. Treatment is essentially supportive; role of antiviral agents is yet to be established. Prevention entails home isolation of suspected cases and those with mild illnesses and strict infection control measures at hospitals that include contact and droplet precautions. The virus spreads faster than its two ancestors the SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), but has lower fatality. The global impact of this new epidemic is yet uncertain.

摘要

一种新的公共卫生危机正在威胁着世界,其病原体是 2019 年新型冠状病毒(2019-nCoV),也被称为严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)。该病毒源自蝙蝠,于 2019 年 12 月在中国湖北省武汉市通过未知的中间宿主动物传播给人类。截至 2020 年 3 月 5 日,全球已报告约 96000 例 2019 冠状病毒病(COVID-19)病例,报告死亡病例 3300 余例。该疾病通过吸入或接触受感染者的飞沫传播,潜伏期为 2 至 14 天。其症状通常为发热、咳嗽、喉咙痛、呼吸急促、乏力、不适等。该疾病在大多数人中较为轻微;在一些人中(通常是老年人和患有合并症者),可能会进展为肺炎、急性呼吸窘迫综合征(ARDS)和多器官功能障碍。许多人无症状。估计病死率在 2%至 3%之间。通过特殊的分子检测在呼吸道分泌物中检测到病毒即可确诊。常见的实验室检查结果包括白细胞计数正常/降低,C 反应蛋白(CRP)升高。即使在无症状或轻症患者中,胸部计算机断层扫描通常也异常。目前的治疗主要为支持性治疗;抗病毒药物的作用尚未确定。预防措施包括对疑似病例和轻症患者进行居家隔离,并在医院采取严格的感染控制措施,包括接触和飞沫预防措施。该病毒的传播速度比其两个前体 SARS-CoV 和中东呼吸综合征冠状病毒(MERS-CoV)更快,但病死率更低。这种新的传染病对全球的影响尚不确定。

相似文献

1
A Review of Coronavirus Disease-2019 (COVID-19).新型冠状病毒肺炎(COVID-19)概述。
Indian J Pediatr. 2020 Apr;87(4):281-286. doi: 10.1007/s12098-020-03263-6. Epub 2020 Mar 13.
3
Novel coronavirus pandemic: A clinical overview.新型冠状病毒大流行:临床概述。
S Afr Fam Pract (2004). 2020 Jun 26;62(1):e1-e5. doi: 10.4102/safp.v62i1.5123.
10
COVID-19: a review.新型冠状病毒肺炎:综述
Monaldi Arch Chest Dis. 2020 May 14;90(2). doi: 10.4081/monaldi.2020.1298.

引用本文的文献

本文引用的文献

3
6
[First case of neonate infected with novel coronavirus pneumonia in China].[中国首例新型冠状病毒肺炎感染新生儿]
Zhonghua Er Ke Za Zhi. 2020 Feb 17;58(0):E009. doi: 10.3760/cma.j.issn.0578-1310.2020.0009.
8
Protecting health-care workers from subclinical coronavirus infection.保护医护人员免受亚临床冠状病毒感染。
Lancet Respir Med. 2020 Mar;8(3):e13. doi: 10.1016/S2213-2600(20)30066-7. Epub 2020 Feb 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验